Yubo International Biotech Limited (YBGJ)
OTCMKTS · Delayed Price · Currency is USD
0.0065
-0.0054 (-45.38%)
Aug 21, 2026, 4:00 PM EST

YBGJ Statistics

Total Valuation

YBGJ has a market cap or net worth of 2.03 million. The enterprise value is 3.56 million.

Market Cap2.03M
Enterprise Value 3.56M

Important Dates

The last earnings date was Tuesday, August 18, 2026.

Earnings Date Aug 18, 2026
Ex-Dividend Date n/a

Share Statistics

YBGJ has 170.42 million shares outstanding. The number of shares has increased by 37.66% in one year.

Current Share Class 170.42M
Shares Outstanding 170.42M
Shares Change (YoY) +37.66%
Shares Change (QoQ) n/a
Owned by Insiders (%) 63.23%
Owned by Institutions (%) n/a
Float 22.11M

Valuation Ratios

PE Ratio n/a
Forward PE n/a
PS Ratio 164.17
PB Ratio -0.76
P/TBV Ratio n/a
P/FCF Ratio n/a
P/OCF Ratio n/a
PEG Ratio n/a
Financial Ratio History

Enterprise Valuation

EV / Earnings n/a
EV / Sales 288.57
EV / EBITDA n/a
EV / EBIT n/a
EV / FCF n/a

Financial Position

The company has a current ratio of 0.18

Current Ratio 0.18
Quick Ratio 0.13
Debt / Equity n/a
Debt / EBITDA n/a
Debt / FCF -2.17
Interest Coverage -4,624.43

Financial Efficiency

Return on Equity (ROE) n/a
Return on Assets (ROA) -81.48%
Return on Invested Capital (ROIC) n/a
Return on Capital Employed (ROCE) 42.32%
Weighted Average Cost of Capital (WACC) 4.60%
Revenue Per Employee n/a
Profits Per Employee n/a
Employee Count14
Asset Turnover 0.01
Inventory Turnover 0.13

Taxes

Income Tax n/a
Effective Tax Rate n/a

Stock Price Statistics

The stock price has decreased by -63.50% in the last 52 weeks. The beta is 0.71, so YBGJ's price volatility has been lower than the market average.

Beta (5Y) 0.71
52-Week Price Change -63.50%
50-Day Moving Average 0.02
200-Day Moving Average 0.09
Relative Strength Index (RSI) 49.34
Average Volume (20 Days) 21,072

Short Selling Information

Short Interest n/a
Short Previous Month n/a
Short % of Shares Out n/a
Short % of Float n/a
Short Ratio (days to cover) 0.01

Income Statement

In the last 12 months, YBGJ had revenue of 12,353 and -1.06 million in losses. Loss per share was -0.01.

Revenue12,353
Gross Profit 8,165
Operating Income -1.12M
Pretax Income -1.16M
Net Income -1.06M
EBITDA -1.01M
EBIT -1.12M
Loss Per Share -0.01
Full Income Statement

Balance Sheet

The company has 11,989 in cash and 1.58 million in debt, with a net cash position of -1.57 million or -0.01 per share.

Cash & Cash Equivalents 11,989
Total Debt 1.58M
Net Cash -1.57M
Net Cash Per Share -0.01
Equity (Book Value) -2.66M
Book Value Per Share -0.02
Working Capital -2.74M
Full Balance Sheet

Cash Flow

Operating Cash Flow -727,992
Capital Expenditures n/a
Depreciation & Amortization 118,033
Net Borrowing 667,380
Free Cash Flow -727,992
FCF Per Share -0.00
Full Cash Flow Statement

Margins

Gross Margin 66.10%
Operating Margin -9,096.87%
Pretax Margin -9,386.79%
Profit Margin n/a
EBITDA Margin n/a
EBIT Margin n/a
FCF Margin n/a

Dividends & Yields

YBGJ does not appear to pay any dividends at this time.

Dividend Per Share n/a
Dividend Yield n/a
Dividend Growth (YoY) n/a
Years of Dividend Growth n/a
Payout Ratio n/a
Buyback Yield -37.66%
Shareholder Yield -37.66%
Earnings Yield -52.21%
FCF Yield -35.90%

Fair Value

There are several formulas that can be used to estimate the intrinsic value of a stock.

Lynch Fair Value n/a
Lynch Upside n/a
Graham Number n/a
Graham Upside n/a

Stock Splits

This stock does not have any record of stock splits.

Last Split Date n/a
Split Type n/a
Split Ratio n/a

Scores

YBGJ has an Altman Z-Score of -26.72 and a Piotroski F-Score of 2. A Z-score under 3 suggests an increased risk of bankruptcy.

Altman Z-Score -26.72
Piotroski F-Score 2